Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults
| dc.contributor.author | Stoniute, Akvile | |
| dc.contributor.author | Madhuvrata, Priya | |
| dc.contributor.author | Still, Madeleine | |
| dc.contributor.author | Barron-Millar, Evelyn | |
| dc.contributor.author | Nabi, Ghulam | |
| dc.contributor.author | Omar, Muhammad Imran | |
| dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-05-08T23:18:41Z | |
| dc.date.available | 2024-05-08T23:18:41Z | |
| dc.date.embargoedUntil | 2024-05-09 | |
| dc.date.issued | 2023-05-09 | |
| dc.description | Acknowledgements We would like to thank the following Cochrane Incontinenceeditorial base staff members for their help and support with thisreview: Lindsey Elstub, Eugenie Johnson, Fiona Stewart, ClaireEastaugh and Sheila Wallace. We would also like to thank AndyBryant and Michael Grayling for their statistical support.We also acknowledge the work of the following who supported uswith translation and provision of unpublished data: Sylvia Antonfor translation of a study reported in German; Reto Bloch, for helpwith three German articles; Mrs Jenny Wan Chen for help with trialspublished in Chinese; Yuan Chi for help with two Chinese articles;Pauline Heus for translation of a Dutch study; Professor Junemannfor providing unpublished data; Atsuo Kondo for translation of astudy reported in Japanese; Vittoria Lutje for help with an Italianarticle; Birgit Moehrer for help with assessment of trials publishedin German, Italian and Flemish; Pfizer and their staff (MartinCarlsson, David Newall, Sheila Quinn, Mike Redino and JosephWang) for providing unpublished data for six trials; Dr Life Rentzhogand Professor Wolfgang Dorschner for providing unpublished data;Professor Stohrer for providing unpublished data; Fiona Stewart forhelp with a Spanish article; Fernanda Teixeira for help with trialspublished in Spanish; and Liliya Eugenevna Ziganshina for helpwith a Russian article.The authors would also like to thank contributors (as authorsor editorial base staff) to previous versions of this review: JuneCody, Gaye Ellis, Cathryn MA Glazener, Jean C Hay-Smith, PeterHerbison, Erika Magnago, Susanne MacDonald and Ghulam Nabi;and U Azman, C Chapple, P Collin, S Radley and D Richmond forauthoring a previous protocol for this review.Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults (Review)Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 277 | |
| dc.format.extent | 2648947 | |
| dc.identifier | 245797546 | |
| dc.identifier | 9d0ba393-8f91-415d-a5de-4242b63a8f3a | |
| dc.identifier | 37160401 | |
| dc.identifier | 85158895684 | |
| dc.identifier.citation | Stoniute, A, Madhuvrata, P, Still, M, Barron-Millar, E, Nabi, G & Omar, M I 2023, 'Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults', The Cochrane database of systematic reviews, vol. 5, no. 5, CD003781. https://doi.org/10.1002/14651858.CD003781.pub3 | en |
| dc.identifier.doi | 10.1002/14651858.CD003781.pub3 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 1469-493X | |
| dc.identifier.other | PubMedCentral: PMC10167789 | |
| dc.identifier.other | ORCID: /0000-0002-1597-3126/work/135245060 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23430 | |
| dc.identifier.vol | 5 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Cochrane database of systematic reviews | en |
| dc.subject | Adult | en |
| dc.subject | Humans | en |
| dc.subject | Cholinergic Antagonists/adverse effects | en |
| dc.subject | Quality of Life | en |
| dc.subject | Tolterodine Tartrate | en |
| dc.subject | Urinary Bladder, Overactive/drug therapy | en |
| dc.subject | Systematic Reviews as Topic | en |
| dc.subject | Drug-Related Side Effects and Adverse Reactions | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Stoniute_etal_CDSR_Oral_Anticholinergic_Drugs_VoR.pdf
- Size:
- 2.53 MB
- Format:
- Adobe Portable Document Format
